Endo Pharmaceuticals Presents at Stifel Nicolaus Conference

September 04 23:38 2011 Print This Article

EndoLogoEndo Pharmaceuticals announced that Blaine Davis, vice president corporate affairs will present a corporate overview at the Stifel Nicolaus Annual Healthcare Conference on Thursday, September 8, 2011 at 11:30 a.m. ET. The conference will be held at the Four Seasons Hotel in Boston, MA.

A live webcast and audio archive of the presentation will be available on the company’s website at http://www.endo.com/. Click on Investor Relations, and then the link to the Event and Presentation. Participants should allow approximately ten minutes prior to the presentation’s start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Endo
Endo Pharmaceuticals is a U.S.-based, specialty healthcare solutions company with a diversified business model, operating in three key business segments – branded pharmaceuticals, generics and devices and services. We deliver an innovative suite of complementary products and services to meet the needs of patients in areas such as pain management, pelvic health, urology, endocrinology and oncology. For more information about Endo Pharmaceuticals, and its wholly owned subsidiaries American Medical Systems, HealthTronics, Inc. and Qualitest Pharmaceuticals, please visit http://www.endo.com/.

SOURCE Endo Pharmaceuticals
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Endo Pharmaceuticals business which are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s Annual Report or Form 10-K for the most recently ended fiscal year.

CHADDS FORD, Pa., Aug. 25, 2011 /PRNewswire via COMTEX/

  Categories: